- Home
- VMD vs VNDA Comparison
VMD vs VNDA Comparison
Compare VMD & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMD
- VNDA
- Stock Information
- Founded
- VMD 2006
- VNDA 2002
- Country
- VMD United States
- VNDA United States
- Employees
- VMD N/A
- VNDA N/A
- Industry
- VMD
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- VMD
- VNDA Health Care
- Exchange
- VMD Nasdaq
- VNDA Nasdaq
- Market Cap
- VMD 279.4M
- VNDA 237.9M
- IPO Year
- VMD N/A
- VNDA 2006
- Fundamental
- Price
- VMD $6.65
- VNDA $4.34
- Analyst Decision
- VMD
- VNDA Strong Buy
- Analyst Count
- VMD 0
- VNDA 3
- Target Price
- VMD N/A
- VNDA $15.33
- AVG Volume (30 Days)
- VMD 190.9K
- VNDA 519.0K
- Earning Date
- VMD 05-07-2025
- VNDA 05-07-2025
- Dividend Yield
- VMD N/A
- VNDA N/A
- EPS Growth
- VMD 19.95
- VNDA N/A
- EPS
- VMD 0.30
- VNDA N/A
- Revenue
- VMD $232,793,000.00
- VNDA $201,351,000.00
- Revenue This Year
- VMD $17.35
- VNDA $16.86
- Revenue Next Year
- VMD $12.87
- VNDA $39.78
- P/E Ratio
- VMD $22.20
- VNDA N/A
- Revenue Growth
- VMD 19.97
- VNDA 13.37
- 52 Week Low
- VMD $6.14
- VNDA $3.81
- 52 Week High
- VMD $9.81
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- VMD 46.10
- VNDA 51.79
- Support Level
- VMD $6.36
- VNDA $4.17
- Resistance Level
- VMD $6.84
- VNDA $4.41
- Average True Range (ATR)
- VMD 0.21
- VNDA 0.16
- MACD
- VMD -0.01
- VNDA 0.03
- Stochastic Oscillator
- VMD 52.78
- VNDA 73.61
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.